The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Misoprostol: Pharmacokinetic profiles, effects on the uterus and side‐effects
Abstract
Misoprostol, a synthetic prostaglandin E1 analogue, is commonly used for medical abortion, cervical priming, the management of miscarriage, induction of labor and the management of postpartum hemorrhage. It can be given orally, vaginally, sublingually, buccally or rectally. Studies of misoprostol's pharmacokinetics and effects on uterine activity have demonstrated the properties of the drug after various routes of administration. These studies can help to discover the optimal dose and route of administration of misoprostol for individual clinical applications. Misoprostol is a safe drug but serious complications and teratogenicity can occur with unsupervised use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Absorption kinetics of misoprostol with oral or vaginal administration
ZIEMAN, M., FONG, S., BENOWITZ, N., BANSKTER, D., & DARNEY, P. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00111-7 · Cited by 637
Pharmacokinetics of different routes of administration of misoprostol
Tang, O. S. (2002) · Human Reproduction · doi:10.1093/humrep/17.2.332 · Cited by 490
Self-citationInduction of Abortion with Mifepristone (RU 486) and Oral or Vaginal Misoprostol
El-Refaey, H., Rajasekar, D., Abdalla, M., Calder, L., & Templeton, A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321502 · Cited by 387
Derman, R. J., Kodkany, B. S., Goudar, S. S., Geller, S. E., Naik, V. A., Bellad, M., Patted, S. S., Patel, A., Edlavitch, S. A., Hartwell, T., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69522-6 · Cited by 295
Use of Misoprostol during Pregnancy and Möbius' Syndrome in Infants
Pastuszak, A. L., Schüler, L., Speck-Martins, C. E., Coelho, K.-E. F. A., Cordello, S. M., Vargas, F., Brunoni, D., Schwarz, I. V. D., Larrandaburu, M., Safattle, H., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806253382604 · Cited by 272
Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone
Norman, J. E., Thong, K. J., & Baird, D. T. (1991) · The Lancet · doi:10.1016/0140-6736(91)92102-8 · Cited by 256
Fatal Toxic Shock Syndrome Associated with Clostridium sordellii after Medical Abortion
Fischer, M., Bhatnagar, J., Guarner, J., Reagan, S., Hacker, J. K., Van Meter, S. H., Poukens, V., Whiteman, D. B., Iton, A., Cheung, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051620 · Cited by 249
Plaut, M. M., Schwartz, M. L., & Lubarsky, S. L. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70049-9 · Cited by 243
Comparison between oral and vaginal administration of misoprostol on uterine contractility
Danielsson, K. (1999) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00436-0 · Cited by 231
Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy
HO, P., NGAI, S., LIU, K., WONG, G., & LEE, S. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00419-5 · Cited by 218
Self-citation
Cited by
Misoprostol for intrauterine device placement
Zapata, L. B., Snyder, E., Nguyen, A. T., Kapp, N., Ti, A., Whiteman, M. K., & Curtis, K. M. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015584.pub2 · Cited by 3
Metadata
- Authors
- Tang, O. S., Gemzell‐Danielsson, K., & Ho, P. C.
- Venue
- International Journal of Gynecology & Obstetrics
- Publisher
- Wiley
- Published
- 2007-10-26
- Volume
- 99
- Issue
- S2
- Pages
- S160-7
- ISSN
- 0020-6695 (ISSN-L)
- 0020-7292
- 1879-3479
- OpenAlex
- W2161872135
- Cited by
- 376
- References
- 25
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Misoprostol: Pharmacokinetic profiles, effects on the uterus and side‐effects. https://app.cochat.ai/papers/10.1016/j.ijgo.2007.09.004
- The paper
- Tang, O. S., Gemzell‐Danielsson, K., & Ho, P. C. (2007). Misoprostol: Pharmacokinetic profiles, effects on the uterus and side‐effects. International Journal of Gynecology & Obstetrics. https://doi.org/10.1016/j.ijgo.2007.09.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.